Outcome of invasive electrophysiological procedures and gender: Are males and females the same?

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 5, 2011, Pages 605-612

  Santangeli, Pasquale ^a,b   Di Biase, Luigi ^b,c,d   Pelargonio, Gemma ^a   Natale, Andrea ^b,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^c The University of Texas at Austin   (United States)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

atrial fibrillation; cardiac resynchronization therapy; gender differences; implantable cardioverter defibrillator; radiofrequency catheter ablation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; CLINICAL FEATURE; DEFIBRILLATOR; HEART ACCESSORY CONDUCTION PATHWAY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FAILURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; INVASIVE PROCEDURE; LUTEAL PHASE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REENTRY TACHYCARDIA; REVIEW; RISK FACTOR; SEX DIFFERENCE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL;

ARRHYTHMIAS, CARDIAC; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 79955892481     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01920.x     Document Type: Review

References (61)

1. Centers for Disease Control and Prevention (CDC): Morbidity and Mortality Weekly Report (MMWR). Available at 2009. Accessed June 2010.
2. Goyal R, Zivin A, Souza J, Shaikh SA, Harvey M, Bogun F, Daoud E, Man KC, Strickberger SA, Morady F,: Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J 1996; 132: 765-767. (Pubitemid 26366973)
3. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ,: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003; 108: 1871-1909. (Pubitemid 37303907)
4. Rodriguez LM, de Chillou C, Schlapfer J, Metzger J, Baiyan X, Van Den Dool A, Smeets JL, Wellens HJ,: Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 1992; 70: 1213-1215.
5. Zimetbaum P, Josephson ME,: Evaluation of patients with palpitations. N Engl J Med 1998; 338: 1369-1373.
6. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, Holmes DR Jr, Gersh BJ,: A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 1993; 87: 866-873. (Pubitemid 23070818)
7. Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, Cai JJ, Madsen N, Wilber DJ,: Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004; 1: 393-396. (Pubitemid 39462609)
8. Hu YF, Huang JL, Wu TJ, Higa S, Shih CM, Tai CT, Lin YJ, Chang SL, Lo LW, Ta-Chuan T, Chang CJ, Tsai WC, Lee PC, Tsao HM, Ishigaki S, Oyakawa A, Chen SA,: Gender differences of electrophysiological characteristics in focal atrial tachycardia. Am J Cardiol 2009; 104: 97-100.
9. Saba S, Zhu W, Aronovitz MJ, Estes NA 3rd, Wang PJ, Mendelsohn ME, Karas RH,: Effects of estrogen on cardiac electrophysiology in female mice. J Cardiovasc Electrophysiol 2002; 13: 276-280. (Pubitemid 34259213)
10. Myerburg RJ, Cox MM, Interian A Jr, Mitrani R, Girgis I, Dylewski J, Castellanos A,: Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures. Am J Cardiol 1999; 83: 1049-1054. (Pubitemid 29162789)
11. Rosano GM, Leonardo F, Sarrel PM, Beale CM, De Luca F, Collins P,: Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996; 347: 786-788. (Pubitemid 26091641)
12. Liuba I, Jonsson A, Safstrom K, Walfridsson H,: Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006; 97: 384-388. (Pubitemid 43133055)
13. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ,: Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301: 1080-1085. (Pubitemid 10217084)
14. Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SK, Liem LB, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E,: Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999; 99: 262-270. (Pubitemid 29056369)
15. Dagres N, Clague JR, Breithardt G, Borggrefe M,: Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol 2003; 42: 1103-1107. (Pubitemid 37108601)
16. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA,: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
17. Hnatkova K, Waktare JE, Murgatroyd FD, Guo X, Camm AJ, Malik M,: Age and gender influences on rate and duration of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1998; 21: 2455-2458.
18. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D,: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952. (Pubitemid 28446646)
19. Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Levy S, Cobbe S, Kremastinos DT, Breithardt G, Cokkinos DV, Crijns HJ,: Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49: 572-577. (Pubitemid 46177436)
20. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR,: Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990; 65: 1112-1116. (Pubitemid 20135821)
21. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, Frison L, Halperin JL,: Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 2006; 27: 1947-1953. (Pubitemid 44297369)
22. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH,: Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270: 2590-2597. (Pubitemid 23346699)
23. Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, Pitt B, Schwartz PJ, Veltri EP, Waldo AL,: Mortality in the survival with ORal D-sotalol (SWORD) trial: Why did patients die Am J Cardiol 1998; 81: 869-876. (Pubitemid 28204641)
24. Lehmann MH, Hardy S, Archibald D, quart B, MacNeil DJ,: Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 1996; 94: 2535-2541.
25. Forleo GB, Tondo C, De Luca L, Dello Russo A, Casella M, De Sanctis V, Clementi F, Fagundes RL, Leo R, Romeo F, Mantica M,: Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007; 9: 613-620. (Pubitemid 47263791)
26. Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, Bassouni M, Cummings J, Wang Y, Lewis WR, Diaz A, Horton RP, Beheiry S, Hongo R, Gallinghouse GJ, Zagrodzky JD, Bailey SM, Al-Ahmad A, Wang P, Schweikert RA, Natale A,: Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167-172.
27. Lee SH, Tai CT, Hsieh MH, Tsao HM, Lin YJ, Chang SL, Huang JL, Lee KT, Chen YJ, Cheng JJ, Chen SA,: Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: Implication for catheter ablation. J Am Coll Cardiol 2005; 46: 1054-1059.
28. Jones PP, Snitker S, Skinner JS, Ravussin E,: Gender differences in muscle sympathetic nerve activity: Effect of body fat distribution. Am J Physiol 1996; 270: E363-E366.
29. Roten L, Rimoldi SF, Schwick N, Sakata T, Heimgartner C, Fuhrer J, Delacretaz E, Tanner H,: Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol 2009; 32: 622-626.
30. Natale A, Newby KH, Pisano E, Leonelli F, Fanelli R, Potenza D, Beheiry S, Tomassoni G,: Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35: 1898-1904. (Pubitemid 30342873)
31. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS,: Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): A multicentre randomised controlled trial. Lancet 2010; 375: 31-40.
32. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME,: Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357: 2657-2665.
33. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H,: Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: The multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008; 118: 2773-2782.
34. Brunner M, Olschewski M, Geibel A, Bode C, Zehender M,: Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004; 25: 88-95. (Pubitemid 38055597)
35. El-Chami MF, Hanna IR, Bush H, Langberg JJ,: Impact of race and gender on cardiac device implantations. Heart Rhythm 2007; 4: 1420-1426. (Pubitemid 47591397)
36. Lamas GA, Pashos CL, Normand SL, McNeil B,: Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995; 91: 1063-1069.
37. Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG, Schmidt H, Sperzel J, Zegelman M,: Do gender differences exist in pacemaker implantation? Results of an obligatory external quality control program. Europace 2010; 12: 210-215.
38. Pyatt JR, Somauroo JD, Jackson M, Grayson AD, Osula S, Aggarwal RK, Charles RG, Connelly DT,: Long-term survival after permanent pacemaker implantation: Analysis of predictors for increased mortality. Europace 2002; 4: 113-119. (Pubitemid 36104662)
39. Schuppel R, Buchele G, Batz L, Koenig W,: Sex differences in selection of pacemakers: Retrospective observational study. BMJ 1998; 316: 1492-1495.
40. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA,: Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007; 357: 1000-1008. (Pubitemid 47367079)
41. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA,: Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009; 119: 1078-1084.
42. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW,: The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497. (Pubitemid 43866387)
43. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Riegel B, Tarkington LG, Yancy CW,: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408. (Pubitemid 351771339)
44. Tung R, Zimetbaum P, Josephson ME,: A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52: 1111-1121.
45. Pelargonio G, Bisceglia C,: Differences between women and men with ICDs: Myth or reality J Cardiovasc Electrophysiol 2009; 20: 979-981.
46. Russo AM, Day JD, Stolen K, Mullin CM, Doraiswamy V, Lerew DL, Olshansky B,: Implantable cardioverter defibrillators: Do women fare worse than men? Gender comparison in the INTRINSIC RV trial. J Cardiovasc Electrophysiol 2009; 20: 973-978.
47. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH,: Primary prevention with defibrillator therapy in women: Results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 2008; 19: 720-724.
48. Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE,: Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004; 15: 993-998. (Pubitemid 39281526)
49. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H,: Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005; 16: 1265-1270.
50. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A,: Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis. Heart Rhythm 2010; 7: 876-882.
51. Wigginton JG, Pepe PE, Bedolla JP, DeTamble LA, Atkins JM,: Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: A multiyear, prospective, population-based study. Crit Care Med 2002; 30: S131-S136. (Pubitemid 34298960)
52. Kannel WB, Wilson PW, D'Agostino RB, Cobb J,: Sudden coronary death in women. Am Heart J 1998; 136: 205-212. (Pubitemid 28368840)
53. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA,: Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298: 1517-1524. (Pubitemid 47529385)
54. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM,: Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
55. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
56. Abraham WT,: Cardiac resynchronization therapy for heart failure: Biventricular pacing and beyond. Curr Opin Cardiol 2002; 17: 346-352. (Pubitemid 34864601)
57. Bleeker GB, Schalij MJ, Boersma E, Steendijk P, van der Wall EE, Bax JJ,: Does a gender difference in response to cardiac resynchronization therapy exist Pacing Clin Electrophysiol 2005; 28: 1271-1275. (Pubitemid 43951386)
58. Lilli A, Ricciardi G, Porciani MC, Perini AP, Pieragnoli P, Musilli N, Colella A, Del Pace S, Michelucci A, Turreni F, Sassara M, Achilli A, Barold SS, Padeletti L,: Cardiac resynchronization therapy: Gender related differences in left ventricular reverse remodeling. Pacing Clin Electrophysiol 2007; 30: 1349-1355. (Pubitemid 350043826)
59. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB,: Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: Analysis of the MIRACLE study. J Interv Card Electrophysiol 2005; 12: 107-113. (Pubitemid 40386293)
60. Di Biase L, Auricchio A, Sorgente A, Civello K, Klersy C, Faletra F, Riedlbauchova L, Patel D, Arruda M, Schweikert RA, Martin DO, Saliba WI, Moccetti T, Wilkoff BL, Natale A,: The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy. Eur Heart J 2008; 29: 2497-2505.
61. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W,: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.